Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :29158380
Publication Date : //

Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity.


Cancer immunotherapy has emerged as a promising therapeutic intervention. However, complete and durable responses are only seen in a fraction of patients who have cancer. A key factor that limits therapeutic success is the infiltration of tumors by cells of the myeloid lineage. The inhibitory receptor signal regulatory protein-α (SIRPα) is a myeloid-specific immune checkpoint that engages the "don't eat me" signal CD47 expressed on tumors and normal tissues. We therefore developed the monoclonal antibody KWAR23, which binds human SIRPα with high affinity and disrupts its binding to CD47. Administered by itself, KWAR23 is inert, but given in combination with tumor-opsonizing monoclonal antibodies, KWAR23 greatly augments myeloid cell-dependent killing of a collection of hematopoietic and nonhematopoietic human tumor-derived cell lines. Following KWAR23 antibody treatment in a human SIRPA knockin mouse model, both neutrophils and macrophages infiltrate a human Burkitt's lymphoma xenograft and inhibit tumor growth, generating complete responses in the majority of treated animals. We further demonstrate that a bispecific anti-CD70/SIRPα antibody outperforms individually delivered antibodies in specific types of cancers. These studies demonstrate that SIRPα blockade induces potent antitumor activity by targeting multiple myeloid cell subsets that frequently infiltrate tumors. Thus, KWAR23 represents a promising candidate for combination therapy.

Authors : Ring Nan Guo , Herndler-Brandstetter Dietmar , Weiskopf Kipp , Shan Liang , Volkmer Jens-Peter , George Benson M , Lietzenmayer Melanie , McKenna Kelly M , Naik Tejaswitha J , McCarty Aaron , Zheng Yunjiang , Ring Aaron M , Flavell Richard A , Weissman Irving L ,

Related products :

Catalog number Product name Quantity
2044-25 CHS-828 A pyridyl cyanoguanidine derivative that displays potent antitumor activity 25 mg
2044-5 CHS-828 A pyridyl cyanoguanidine derivative that displays potent antitumor activity 5 mg
30-655 DNTTIP1 binds DNA and enhances the activity of terminal deoxynucleotidyltransferase (TDT, or DNTT), a DNA polymerase that catalyzes the polymerization of DNA in the absence of a DNA template. 0.1 mg
orb82779 Human TNF alpha Variant protein The clinical use of the potent antitumor activity of TNF-alpha has been limited by the proinflammatory side effects including fever, dose-limiting hypotension, hepatoto 1 mg
EIAAB38503 CD172 antigen-like family member B,Homo sapiens,Human,Signal-regulatory protein beta-2,Signal-regulatory protein gamma,SIRPB2,SIRP-b2,SIRP-beta-2,SIRPG,SIRP-gamma
29-706 IL18RAP is an accessory subunit of the heterodimeric receptor for IL18. This protein enhances the IL18 binding activity of IL18R1 (IL1RRP), a ligand binding subunit of IL18 receptor. The coexpression 0.1 mg
24015 Primary antibody SIRP alpha Antibody, Source Rabbit, Species Reactivity Recognizes SIRP alpha 1, 2 and 3. 100ug
15-288-21487 Tyrosine-protein phosphatase non-receptor type substrate 1 - SHP substrate 1; SHPS-1; Inhibitory receptor SHPS-1; Signal-regulatory protein alpha-1; Sirp-alpha-1; Sirp-alpha-2; Sirp-alpha-3; MyD-1 ant 0.05 mg
15-288-21487 Tyrosine-protein phosphatase non-receptor type substrate 1 - SHP substrate 1; SHPS-1; Inhibitory receptor SHPS-1; Signal-regulatory protein alpha-1; Sirp-alpha-1; Sirp-alpha-2; Sirp-alpha-3; MyD-1 ant 0.1 mg
18-661-15013 Tyrosine-protein phosphatase non-receptor type substrate 1 - SHP substrate 1; SHPS-1; Inhibitory receptor SHPS-1; Signal-regulatory protein alpha-1; Sirp-alpha-1; Sirp-alpha-2; Sirp-alpha-3; MyD-1 ant 0.1 mg
YONCBA14L CD13, Macrophage, Monocyte, Neutrophil, Clone 3D8, Mab anti_Human 5 ml.
YSRTMCA355 Neutrophil, cytoplasmic antigen, Macrophage, Clone YTH8.18, Rat Mab anti_Human; frozen, IH vial
YSRTMCA1218 Swine Monocyte, Macrophage, Neutrophil, Clone MIL2, Mab anti_Mink; frozen, IH_flow 2 ml.
EIAAB38325 Bos taurus,Bovine,CD172 antigen-like family member A,Inhibitory receptor SHPS-1,MYD1,MyD-1 antigen,PTPNS1,SHP substrate 1,SHPS1,SHPS-1,Signal-regulatory protein alpha-1,SIRP,SIRPA,Sirp-alpha-1,Tyrosin
26-671 DPPA2 may play a role in maintaining cell pluripotentiality. ECSA_DPPA2 is a promising target for antigen-specific immunotherapy in non-small cell lung cancers. 0.05 mg
orb61352 Paclitaxel Antitumor and antileukemic agent isolated from the bark of the yew tree For research use only. 1 g
10-663-45035 GRO-Alpha_MGSA (CXCL1) Human - CXCL1; Melanoma growth stimulatory activity; MGSA; Neutrophil-activating protein 3; NAP-3; GRO-alpha(1-73) N_A 1 mg
10-663-45035 GRO-Alpha_MGSA (CXCL1) Human - CXCL1; Melanoma growth stimulatory activity; MGSA; Neutrophil-activating protein 3; NAP-3; GRO-alpha(1-73) N_A 0.025 mg
10-663-45035 GRO-Alpha_MGSA (CXCL1) Human - CXCL1; Melanoma growth stimulatory activity; MGSA; Neutrophil-activating protein 3; NAP-3; GRO-alpha(1-73) N_A 0.005 mg
30-276 GDE1 has glycerophosphoinositol phosphodiesterase activity. It has little or no activity towards glycerophosphocholine. GDE1 activity can be modulated by G-protein signaling pathways. 0.05 mg
bs-2708R Rabbit Anti-SIRP Alpha Polyclonal Antibody 100ul
YF-PA22321 anti-SIRP 50 ul
YF-MA19886 anti-SIRP (4C7) 100 ug
bs-2708R-PE-Cy5.5 Rabbit Anti-SIRP Alpha Polyclonal Antibody, PE-Cy5.5 Conjugated 100ul
bs-2708R-PE Rabbit Anti-SIRP Alpha Polyclonal Antibody, PE Conjugated 100ul


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur